People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rivermark Medical, Inc. | — | Healthtech | Series B | $35.9M | $188.7M | 2021 |
| Koya Medical, Inc. | — | Healthtech | Series A | $11.0M | $209.4M | 2020 |
| Lhotse Medical, Inc. | — | Healthtech | Seed | $3.7M | $4.8M | 2023 |
Anand Doraiswamy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anand Doraiswamy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Josh Baltzell | 3 | 7 |
| Carter Meyer | 2 | 14 |
| Jan Garfinkle | 1 | 7 |
| Christopher Kaster | 1 | 5 |
| Scott Button | 1 | 4 |
| Joseph Biller | 1 | 3 |
| Chris Kaster | 1 | 3 |
| Matthew Ercolani | 1 | 1 |
| Adam Kadlec | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.